Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application
Currently, research on terbium has gained a momentum owing to its four short-lived radioisotopes, 149Tb, 152Tb, 155Tb, and 161Tb, all of which can be considered in one or another field of nuclear medicine. The members of this emerging quadruplet family have appealing nuclear characteristics and have...
Main Authors: | Nabanita Naskar, Susanta Lahiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.675014/full |
Similar Items
-
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
by: Cristina Müller, et al.
Published: (2016-03-01) -
Biological Pathways as Substantiation of the Use of Copper Radioisotopes in Cancer Theranostics
by: Dana Niculae, et al.
Published: (2021-01-01) -
Special Issue ”Instruments and Methods for Cyclotron Produced Radioisotopes”
by: Saverio Braccini, et al.
Published: (2019-11-01) -
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
by: Cristina Müller, et al.
Published: (2014-03-01) -
New method for determination of temperature in spallation reactions
by: Jordanov Dragana J., et al.
Published: (2011-01-01)